TRCT
MJN

Tower Research Capital (TRC)’s Mead Johnson Nutrition Company MJN Stock Holding History

Tower Research Capital (TRC)’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-517
Closed -$46K – 3969
2017
Q1 		$46K Sell
517
-759
-59% -$62.4K ﹤0.01% 783
2016
Q4 		$90K Buy
+1,276
New +$95.1K 0.01% 1033
2016
Q3 		– Sell
-5,152
Closed -$468K – 5107
2016
Q2 		$468K Buy
+5,152
New +$436K 0.04% 294
2016
Q1 		– Sell
-20
Closed -$2K – 5519
2015
Q4 		$2K Buy
+20
New +$1.57K ﹤0.01% 3928
2015
Q2 		– Sell
-959
Closed -$96K – 5443
2015
Q1 		$96K Buy
+959
New +$96.7K 0.01% 939
2014
Q4 		– Sell
-263
Closed -$26K – 5173
2014
Q3 		$26K Sell
263
-278
-51% -$26.3K ﹤0.01% 2099
2014
Q2 		$50K Sell
541
-1,484
-73% -$130K 0.01% 1307
2014
Q1 		$168K Sell
2,025
-273
-12% -$22.1K 0.02% 469
2013
Q4 		$193K Sell
2,298
-4,769
-67% -$388K 0.03% 539
2013
Q3 		$525K Buy
7,067
+6,164
+683% +$462K 0.06% 305
2013
Q2 		$72K Buy
+903
New +$72.4K 0.01% 683

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Tower Research Capital (TRC)'s MJN Position: Q2 2017 in Review

Tower Research Capital (TRC) sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 517 shares — an estimated $46K sold.

Tower Research Capital (TRC) first reported a position in MJN in Q2 2013 and held it in 11 quarters. The position peaked at $525K in Q3 2013. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Tower Research Capital (TRC) reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 517 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $46K.
  • Tower Research Capital (TRC) first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s Mead Johnson Nutrition Company position peaked at $525K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.